Pfizer is buying Toronto and Cambridge, Massachusetts-based Trillium Therapeutics in a deal worth $2.26 billion. Trillium focuses on developing a new set of checkpoint inhibitors to treat cancer.

The Securities and Exchange Commission (SEC) is charging Matthew Panuwat – a former business development executive at Medivation – with insider trading, according to a complaint filed in court stemming from Pfizer’s acquisition of Medivation in 2016.

Philip Morris continues to expand the tobacco giant’s ‘Beyond Nicotine’ strategy by acquiring Michigan-based OtiTopic, a company developing inhalable acetylsalicylic acid (ASA) treatment for acute myocardial infarction.

Sanofi agreed to buy U.S. biotech company Translate Bio in a $3.2 billion deal, as the French pharmaceuticals firm bets on next-generation mRNA vaccine technology beyond the Covid-19 pandemic, confirming a Reuters exclusive report.

International healthcare and communications group Huntsworth announced the acquisition of U.S.-based medical analytics consultancy MedEvoke.

Med Ad News caught up with Fingerpaint Partner Bill McEllen; Colleen Carter, head of corporate marketing and business development at Fingerpaint; and Splice Co-Founder Paul Hagopian. The West Coast healthcare advertising agency Splice was acquired and will be fully integrated within the full-service health and wellness marketing firm Fingerpaint under the name Fingerpaint Bay Area. They talk about the acquisition and what it means to new employees and current clients.

Fingerpaint, a full-service health and wellness marketing firm with a global team of more than 580 people, acquired Splice, a healthcare communications business based in Emeryville, California.

Omnicom Health Group acquired Archbow Consulting and launched Omni Health, a unique extension of OHG’s marketing operating system Omni.

Leading life science commercialization partner Fishawack Health acquired PRMA Consulting, a premier global market access and health economics outcomes research (HEOR) consultancy with offices across Europe, Asia, and the United States.

Fishawack Health, a leading global commercialization partner for the life sciences industry, announced the acquisition of StoneArch, a Minneapolis-based healthcare marketing agency renowned for strategic, creative and storytelling capabilities.